Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: BREAST NEOPLASMS - METABOLISM , . Treffer: 60

2017

Bayraktar, R; Pichler, M; Kanlikilicer, P; Ivan, C; Bayraktar, E; Kahraman, N; Aslan, B; Oguztuzun, S; Ulasli, M; Arslan, A; Calin, G; Lopez-Berestein, G; Ozpolat, B MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase.
Oncotarget. 2017; 8(7):11641-11658 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Cserni, G; Floris, G; Koufopoulos, N; Kovács, A; Nonni, A; Regitnig, P; Stahls, A; Varga, Z Invasive lobular carcinoma with extracellular mucin production-a novel pattern of lobular carcinomas of the breast. Clinico-pathological description of eight cases.
Virchows Arch. 2017; 471(1):3-12 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Nass, N; Walter, S; Jechorek, D; Weissenborn, C; Ignatov, A; Haybaeck, J; Sel, S; Kalinski, T High neuronatin (NNAT) expression is associated with poor outcome in breast cancer.
Virchows Arch. 2017; 471(1):23-30
Web of Science PubMed FullText FullText_MUG

 

Schramm, A; Schochter, F; Friedl, TWP; de Gregorio, N; Andergassen, U; Alunni-Fabbroni, M; Trapp, E; Jaeger, B; Heinrich, G; Camara, O; Decker, T; Ober, A; Mahner, S; Fehm, TN; Pantel, K; Fasching, PA; Schneeweiss, A; Janni, W; Rack, BK; SUCCESS Study Group Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.
Clin Breast Cancer. 2017; 17(4):279-285
Web of Science PubMed FullText FullText_MUG

 

Tiran, V; Stanzer, S; Heitzer, E; Meilinger, M; Rossmann, C; Lax, S; Tsybrovskyy, O; Dandachi, N; Balic, M Genetic profiling of putative breast cancer stem cells from malignant pleural effusions.
PLoS One. 2017; 12(4):e0175223-e0175223 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Trapp, EK; Majunke, L; Zill, B; Sommer, H; Andergassen, U; Koch, J; Harbeck, N; Mahner, S; Friedl, TWP; Janni, W; Rack, B; Alunni-Fabbroni, M LKB1 pro-oncogenic activity triggers cell survival in circulating tumor cells.
Mol Oncol. 2017; 11(11):1508-1526 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Cerk, S; Schwarzenbacher, D; Adiprasito, JB; Stotz, M; Hutterer, GC; Gerger, A; Ling, H; Calin, GA; Pichler, M Current Status of Long Non-Coding RNAs in Human Breast Cancer.
Int J Mol Sci. 2016; 17(9): [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Chan, AA; Bashir, M; Rivas, MN; Duvall, K; Sieling, PA; Pieber, TR; Vaishampayan, PA; Love, SM; Lee, DJ Characterization of the microbiome of nipple aspirate fluid of breast cancer survivors.
Sci Rep. 2016; 6(36):28061-28061 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kammerer, S; Jahn, SW; Winter, E; Eidenhammer, S; Rezania, S; Regitnig, P; Pichler, M; Schreibmayer, W; Bauernhofer, T Critical evaluation of KCNJ3 gene product detection in human breast cancer: mRNA in situ hybridisation is superior to immunohistochemistry.
J Clin Pathol. 2016; 69(12):1116-1121 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients.
Tumour Biol. 2016; 37(1):361-368 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rasoulzadeh, Z; Ghods, R; Kazemi, T; Mirzadegan, E; Ghaffari-Tabrizi-Wizsy, N; Rezania, S; Kazemnejad, S; Arefi, S; Ghasemi, J; Vafaei, S; Mahmoudi, AR; Zarnani, AH Placental Kisspeptins Differentially Modulate Vital Parameters of Estrogen Receptor-Positive and -Negative Breast Cancer Cells.
PLoS One. 2016; 11(4):e0153684-e0153684 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Rezania, S; Kammerer, S; Li, C; Steinecker-Frohnwieser, B; Gorischek, A; DeVaney, TT; Verheyen, S; Passegger, CA; Tabrizi-Wizsy, NG; Hackl, H; Platzer, D; Zarnani, AH; Malle, E; Jahn, SW; Bauernhofer, T; Schreibmayer, W Overexpression of KCNJ3 gene splice variants affects vital parameters of the malignant breast cancer cell line MCF-7 in an opposing manner.
BMC Cancer. 2016; 16(1):628-628 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Sigl, V; Owusu-Boaitey, K; Joshi, PA; Kavirayani, A; Wirnsberger, G; Novatchkova, M; Kozieradzki, I; Schramek, D; Edokobi, N; Hersl, J; Sampson, A; Odai-Afotey, A; Lazaro, C; Gonzalez-Suarez, E; Pujana, MA; Cimba, F; Heyn, H; Vidal, E; Cruickshank, J; Berman, H; Sarao, R; Ticevic, M; Uribesalgo, I; Tortola, L; Rao, S; Tan, Y; Pfeiler, G; Lee, EY; Bago-Horvath, Z; Kenner, L; Popper, H; Singer, C; Khokha, R; Jones, LP; Penninger, JM RANKL/RANK control Brca1 mutation- .
Cell Res. 2016; 26(7):761-774 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Tramm, T; Kim, JY; Leibl, S; Moinfar, F; Tavassoli, FA Expression of C-KIT, CD24, CD44s, and COX2 in benign and non-invasive apocrine lesions of the breast.
Virchows Arch. 2016; 469(3):285-295
Web of Science PubMed FullText FullText_MUG

 

Trivanović, D; Jauković, A; Krstić, J; Nikolić, S; Okić Djordjević, I; Kukolj, T; Obradović, H; Mojsilović, S; Ilić, V; Santibanez, JF; Bugarski, D Inflammatory cytokines prime adipose tissue mesenchymal stem cells to enhance malignancy of MCF-7 breast cancer cells via transforming growth factor-β1.
IUBMB Life. 2016; 68(3): 190-200. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Bollen, L; Wibmer, C; Wang, M; van der Linden, YM; Leithner, A; Bünger, CE; Jensen, AB; Fiocco, M; Bratschitsch, G; Pondaag, W; Bovée, JV; Dijkstra, PD Molecular phenotype is associated with survival in breast cancer patients with spinal bone metastases.
Clin Exp Metastasis. 2015; 32(1):1-5
Web of Science PubMed FullText FullText_MUG

 

Gnant, M; Sestak, I; Filipits, M; Dowsett, M; Balic, M; Lopez-Knowles, E; Greil, R; Dubsky, P; Stoeger, H; Rudas, M; Jakesz, R; Ferree, S; Cowens, JW; Nielsen, T; Schaper, C; Fesl, C; Cuzick, J Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype.
Ann Oncol. 2015; 26(8):1685-1691 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Leitner, L; Jürets, A; Itariu, BK; Keck, M; Prager, G; Langer, F; Grablowitz, V; Zeyda, M; Stulnig, TM Osteopontin promotes aromatase expression and estradiol production in human adipocytes.
Breast Cancer Res Treat. 2015; 154(1):63-69
Web of Science PubMed FullText FullText_MUG

 

Li, C; Rezania, S; Kammerer, S; Sokolowski, A; Devaney, T; Gorischek, A; Jahn, S; Hackl, H; Groschner, K; Windpassinger, C; Malle, E; Bauernhofer, T; Schreibmayer, W Piezo1 forms mechanosensitive ion channels in the human MCF-7 breast cancer cell line.
Sci Rep. 2015; 5(2):8364-8364 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pircher, M; Mlineritsch, B; Fridrik, MA; Dittrich, C; Lang, A; Petru, E; Weltermann, A; Thaler, J; Hufnagl, C; Gampenrieder, SP; Rinnerthaler, G; Ressler, S; Ulmer, H; Greil, R Lapatinib-plus-pegylated liposomal doxorubicin in advanced HER2-positive breast cancer following trastuzumab: a phase II trial.
Anticancer Res. 2015; 35(1):517-521
Web of Science PubMed

 

Schwarzenbacher, D; Stiegelbauer, V; Deutsch, A; Ress, AL; Aigelsreiter, A; Schauer, S; Wagner, K; Langsenlehner, T; Resel, M; Gerger, A; Ling, H; Ivan, C; Calin, GA; Hoefler, G; Rinner, B; Pichler, M Low spinophilin expression enhances aggressive biological behavior of breast cancer.
Oncotarget. 2015; 6(13):11191-11202 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2014

Cserni, G; Vörös, A; Liepniece-Karele, I; Bianchi, S; Vezzosi, V; Grabau, D; Sapino, A; Castellano, I; Regitnig, P; Foschini, MP; Zolota, V; Varga, Z; Figueiredo, P; Decker, T; Focke, C; Kulka, J; Kaya, H; Reiner-Concin, A; Amendoeira, I; Callagy, G; Caffrey, E; Wesseling, J; Wells, C Distribution pattern of the Ki67 labelling index in breast cancer and its implications for choosing cut-off values.
Breast. 2014; 23(3):259-263 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Gnant, M; Filipits, M; Greil, R; Stoeger, H; Rudas, M; Bago-Horvath, Z; Mlineritsch, B; Kwasny, W; Knauer, M; Singer, C; Jakesz, R; Dubsky, P; Fitzal, F; Bartsch, R; Steger, G; Balic, M; Ressler, S; Cowens, JW; Storhoff, J; Ferree, S; Schaper, C; Liu, S; Fesl, C; Nielsen, TO; Austrian Breast and Colorectal Cancer Study Group Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.
Ann Oncol. 2014; 25(2):339-345 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Puzovic, V; Brcic, I; Ranogajec, I; Jakic-Razumovic, J Prognostic values of ETS-1, MMP-2 and MMP-9 expression and co-expression in breast cancer patients.
Neoplasma. 2014; 61(4): 439-446. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Pfeiler, G; Stöger, H; Dubsky, P; Mlineritsch, B; Singer, C; Balic, M; Fitzal, F; Moik, M; Kwasny, W; Selim, U; Renner, K; Ploner, F; Steger, GG; Seifert, M; Hofbauer, F; Sandbichler, P; Samonigg, H; Jakesz, R; Greil, R; Fesl, C; Gnant, M; ABCSG Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial.
Br J Cancer. 2013; 108(7):1408-1414 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Schwarzenbacher, D; Balic, M; Pichler, M The role of microRNAs in breast cancer stem cells.
Int J Mol Sci. 2013; 14(7):14712-14723 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2012

Labonte, MJ; Wilson, PM; Yang, D; Zhang, W; Ladner, RD; Ning, Y; Gerger, A; Bohanes, PO; Benhaim, L; El-Khoueiry, R; El-Khoueiry, A; Lenz, HJ The Cyclin D1 (CCND1) A870G polymorphism predicts clinical outcome to lapatinib and capecitabine in HER2-positive metastatic breast cancer.
Ann Oncol. 2012; 23(6):1455-1464 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Petricevic, B; Vrbanec, D; Jakic-Razumovic, J; Brcic, I; Rabic, D; Badovinac, T; Ozimec, E; Bali, V Expression of Toll-like receptor 4 and beta 1 integrin in breast cancer.
Med Oncol. 2012; 29(2): 486-494.
Web of Science PubMed FullText FullText_MUG

 

2011

Balic, M; Rapp, N; Stanzer, S; Lin, H; Strutz, J; Szkandera, J; Daidone, MG; Samonigg, H; Cote, RJ; Dandachi, N Novel immunofluorescence protocol for multimarker assessment of putative disseminating breast cancer stem cells.
Appl Immunohistochem Mol Morphol. 2011; 19(1):33-40
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Peintinger, F Clinical use of nomograms for breast cancer.
J Surg Oncol. 2011; 103(8): 745-745.
Web of Science PubMed FullText FullText_MUG

 

2010

Moinfar, F Flat ductal intraepithelial neoplasia of the breast: evolution of Azzopardi's "clinging" concept.
Semin Diagn Pathol. 2010; 27(1):37-48
Web of Science PubMed FullText FullText_MUG

 

Pristauz, G; Petru, E; Stacher, E; Geigl, JB; Schwarzbraun, T; Tsybrovskyy, O; Winter, R; Moinfar, F Androgen receptor expression in breast cancer patients tested for BRCA1 and BRCA2 mutations.
Histopathology. 2010; 57(6):877-884
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Wagner, V; Stadelmeyer, E; Riederer, M; Regitnig, P; Gorischek, A; Devaney, T; Schmidt, K; Tritthart, HA; Hirschberg, K; Bauernhofer, T; Schreibmayer, W Cloning and characterisation of GIRK1 variants resulting from alternative RNA editing of the KCNJ3 gene transcript in a human breast cancer cell line.
J Cell Biochem. 2010; 110(3):598-608
Web of Science PubMed FullText FullText_MUG

 

2009

Gebeshuber, CA; Zatloukal, K; Martinez, J miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis.
EMBO Rep. 2009; 10(4): 400-405. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

2008

Rudas, M; Lehnert, M; Huynh, A; Jakesz, R; Singer, C; Lax, S; Schippinger, W; Dietze, O; Greil, R; Stiglbauer, W; Kwasny, W; Grill, R; Stierer, M; Gnant, MF; Filipits, M; Austrian Breast and Colorectal Cancer Study Group Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy.
CLIN CANCER RES. 2008; 14(6): 1767-1774. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2007

Schippinger, W; Dandachi, N; Regitnig, P; Hofmann, G; Balic, M; Neumann, R; Samonigg, H; Bauernhofer, T The predictive value of EGFR and HER-2/neu in tumor tissue and serum for response to anthracycline-based neoadjuvant chemotherapy of breast cancer.
Am J Clin Pathol. 2007; 128(4):630-637 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2006

Leibl, S; Moinfar, F Mammary NOS-type sarcoma with CD10 expression: a rare entity with features of myoepithelial differentiation.
Am J Surg Pathol. 2006; 30(4):450-456
Web of Science PubMed FullText FullText_MUG

 

Schippinger, W; Regitnig, P; Dandachi, N; Wernecke, KD; Bauernhofer, T; Samonigg, H; Moinfar, F Evaluation of the prognostic significance of androgen receptor expression in metastatic breast cancer.
Virchows Arch. 2006; 449(1):24-30
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2005

Becker, JC; Straten, PT; Andersen, MH The paradoxical association between Bcl-2 expression and prognosis: does the immune system make the difference?
Cancer Res. 2005; 65(7):2983-2983 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Filipits, M; Pohl, G; Rudas, M; Dietze, O; Lax, S; Grill, R; Pirker, R; Zielinski, CC; Hausmaninger, H; Kubista, E; Samonigg, H; Jakesz, R Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group.
J Clin Oncol. 2005; 23(6):1161-1168 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Leibl, S; Gogg-Kammerer, M; Sommersacher, A; Denk, H; Moinfar, F Metaplastic breast carcinomas: are they of myoepithelial differentiation?: immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers.
Am J Surg Pathol. 2005; 29(3):347-353
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Leibl, S; Moinfar, F Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors?
J CLIN PATHOL 2005 58: 700-704. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Liegl, B; Horn, LC; Moinfar, F Androgen receptors are frequently expressed in mammary and extramammary Paget's disease.
Mod Pathol. 2005; 18(10):1283-1288 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2004

Peintinger, F; Leibl, S; Reitsamer, R; Moinfar, F Primary acinic cell carcinoma of the breast: a case report with long-term follow-up and review of the literature.
HISTOPATHOLOGY. 2004; 45(6): 645-648. (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Wells, CA; Sloane, JP; Coleman, D; Munt, C; Amendoeira, I; Apostolikas, N; Bellocq, JP; Bianchi, S; Boecker, W; Bussolati, G; Connolly, CE; Dervan, P; Drijkoningen, M; Ellis, IO; Elston, CW; Eusebi, V; Faverly, D; Heikkila, P; Holland, R; Jacquemier, J; Lacerda M, Martinez-Penuela J, De Miguel C, Peterse JL, Rank F, Reiner A, Saksela E, Sigal-Zafrani B, Sylvan M, Borisch B, Cserni G, Decker T, Kerner H, Kulka J, Regitnig P, Sapino A, Tanous AM, Thorstenson S, Zozaya E Consistency of staining and reporting of oestrogen receptor immunocytochemistry within the European Union--an inter-laboratory study.
VIRCHOWS ARCHIV. 2004; 445(2): 119-128.
Web of Science PubMed FullText FullText_MUG

 

Wolf, G; Aigner, RM; Schaffler, G; Langsenlehner, U; Renner, W; Samonigg, H; Yazdani-Biuki, B; Krippl, P The 936C>T polymorphism of the gene for vascular endothelial growth factor is associated with 18F-fluorodeoxyglucose uptake.
BREAST CANCER RES TREAT. 2004; 88(3): 205-208.
Web of Science PubMed FullText FullText_MUG

 

2003

Moré, E; Fellner, T; Doppelmayr, H; Hauser-Kronberger, C; Dandachi, N; Obrist, P; Sandhofer, F; Paulweber, B Activation of the MAP kinase pathway induces chicken ovalbumin upstream promoter-transcription factor II (COUP-TFII) expression in human breast cancer cell lines.
J Endocrinol. 2003; 176(1): 83-94. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Wang, C; Pattabiraman, N; Zhou, JN; Fu, M; Sakamaki, T; Albanese, C; Li, Z; Wu, K; Hulit, J; Neumeister, P; Novikoff, PM; Brownlee, M; Scherer, PE; Jones, JG; Whitney, KD; Donehower, LA; Harris, EL; Rohan, T; Johns, DC; Pestell, RG Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation.
Mol Cell Biol. 2003; 23(17):6159-6173 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2002

Dandachi, N; Dietze, O; Hauser-Kronberger, C Chromogenic in situ hybridization: a novel approach to a practical and sensitive method for the detection of HER2 oncogene in archival human breast carcinoma.
Lab Invest. 2002; 82(8):1007-1014 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mannweiler, S; Tsybrovskyy, O; Regauer, S The flow cytometric DNA index can predict the presence of lymph node metastases in invasive ductal breast carcinoma.
APMIS. 2002; 110(7-8):580-586
Web of Science PubMed FullText FullText_MUG

 

Weitere 50 Treffer anzeigen
© Med Uni Graz Impressum